• Non ci sono risultati.

Vertical transmission of antibodies in infants born from mothers with positive serology to COVID-19 pneumonia

N/A
N/A
Protected

Academic year: 2021

Condividi "Vertical transmission of antibodies in infants born from mothers with positive serology to COVID-19 pneumonia"

Copied!
3
0
0

Testo completo

(1)

Since January 2020 Elsevier has created a COVID-19 resource centre with

free information in English and Mandarin on the novel coronavirus

COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the

company's public news and information website.

Elsevier hereby grants permission to make all its COVID-19-related

research that is available on the COVID-19 resource centre - including this

research content - immediately available in PubMed Central and other

publicly funded repositories, such as the WHO COVID database with rights

for unrestricted research re-use and analyses in any form or by any means

with acknowledgement of the original source. These permissions are

granted for free by Elsevier for as long as the COVID-19 resource centre

(2)

Correspondence

Verticaltransmissionofantibodiesininfants

bornfrommotherswithpositiveserologyto

COVID-19pneumonia

DearEditor,

Thereisstillmuchunknownregardingtheimpactofthedisease

onpregnancy.ThemajorityofreportedcasesofCOVID-19infection

inpregnantpatientshaveshownamildorasymptomaticcourseof

thedisease,withonlyfewcasesrequiringintensivecareunit(ICU)

admission, andonly a fewreportedcases requiringmechanical

ventilation1.

Todatethereisnocertaintyifthemothertransmitsserological

protectionthroughtheplacenta.Wedescribetwocasesofmother

withpositiveIGGonperiphericalbloodtest,andtheevidenceIGG

testingpositiveinumbilicalcordsoonafterdelivery.

Serum samples were tested for Sars-CoV-2 antibodies by

using a chemiluminescent microparticle immunoassay (CMIA)

intendedforthequalitativedetectionofIgGantibodiesto

SARS-CoV-2 in human serum. Patient samples were runned on an

automated chemiluminescence analyzer (Architect Abbott) for

thedetectionofspecificserumIgGandIgMinresponseto

SARS-CoV-2 recent or prior infection2. Positivity to Covid-19 was

establishedbythereal-timepolymerasechainreaction(RT-PCR)

onnasopharyngealswab.

ThefirstpatientSJwasadmittedinourcliniconMay15th2020,

resultingpositivetonasopharyngealswabandserologyforCovid

19IGG(Index7.20).ShewasasymptomaticforCovid19,without

fever, cough, and dyspnea and diarrhea. At the admission she

resultedpositivetotheserologyforCovid19IGG(Index7.20)and

thereal-timepolymerasechainreaction(RT-PCR)on

nasopharyn-gealswabwaspositivetoo.Sheunderwentcesareansectiondueto

initiallabor at 37 weeks and polidramnios in double previous

cesareansection.ThebabywasadmittedinNICUbecauseofthe

onset of mild respiratory distress after 30 minutes. Serological

testingonumbilicalcordandperipheralbloodwerepositivefor

Covid19IGG(index7.03).NasopharyngealswabRT-PCRresulted

negativeforCovid 19.The babywas dismissedafter10daysof

oxygenandantibiotictherapy,andherfollowuphasbeensofar

negative.

ThesecondpatientGPwasadmittedinourcliniconJunethe

2nd 2020, resulting positive tothe serology for Covid 19 IGG

(index 8,01) but negative on naso-pharyngeal swab. She was

asymptomatic forCovid19,without fever,cough,dyspnea and

diarrhea.Herobstetrical historywasuncomplicated. She

deliv-ered spontaneously after amniotic rupture. During the birth

serological testingonumbilical cord,amnioticfluidandbaby’s

peripheralbloodwasperformed,andtheyresulted positivefor

Covid19IGG(index7.66).

InourcasesSARS-CoV-19 IgGweredetected inthematernal

serum, andspecificantibodiesweredetected inneonatalblood

serum sampleswithelevated concentrations,similartotheIgG

concentrations of their respective mothers,despite the babies

throatswabwerenegative.

IgGispassivelytransferredacrosstheplacentafrommotherto

fetus,beginning attheendof thesecondtrimesterandreaches

high levels at the time of birth 3, while IgM is not usually

transferredfrommothertofetusbecauseofitslarger

macromo-lecularstructure.

Somestudieshavebeenpublisheddemonstratingthepresence

ofIgMinthenewborn,suggestingthatthebabyhaddevelopedthe

intrauterineinfectionandhehadproducedtheIgMautonomously.

Thehumanfetuseshasbeenfoundcapabletoproduce

immuno-globulinesbuthalflifeofIgMisfivedays4.

ThesefindingsupdatethecaseseriespublishedbyZeng5adding

twocasesWeunderlinetheneedoffurtherstudiestodeepenthe

serological characteristics of infants whose mothers had been

infectedwithSARS-CoV-2,andtheirimmunitytothevirus.

References

[1]ChenH,GuoJ,WangC,etal.Clinicalcharacteristicsandintrauterinevertical transmission potentialof COVID-19 infectionin nine pregnantwomen: a retrospectivereviewofmedicalrecords.TheLancet2020;395(10226):809–15, doi:http://dx.doi.org/10.1016/S0140-6736(20)30360-3.

[2]BryanA,PepperG,WenerMH,etal.PerformancecharacteristicsoftheAbbott architectSARS-CoV-2IgGAssayandSeroprevalenceinBoiseIdaho.,doi:http:// dx.doi.org/10.1128/JCM.00941-20.

[3]Kohler PF,Farr RS.Elevation ofCordover MaternalIgGImmunoglobulin: EvidenceforanActivePlacentalIgGTransport.Nature1966;210(5040):1070–1, doi:http://dx.doi.org/10.1038/2101070a0.

[4]HaiderSA.SerumIgMinDiagnosisofInfectionintheNewborn.ArchDisChild 1972;47(253):382–93,doi:http://dx.doi.org/10.1136/adc.47.253.382. [5]ZengH,XuC,FanJ,etal.AntibodiesinInfantsBorntoMothersWithCOVID-19

Pneumonia. JAMA 2020, doi:http://dx.doi.org/10.1001/jama.2020.4861 Pub-lishedonlineMarch26.

NicolettaVendola

SCOstetriciaeGinecologia,OspedaleSant’Andrea,Vercelli,Italy

Vivianastampini

ObstetricsandGynecologyClinic,UniversityofEasternPiedmont,

Italy

https://doi.org/10.1016/j.ejogrb.2020.08.023

0301-2115/©2020ElsevierB.V.Allrightsreserved.

EuropeanJournalofObstetrics&GynecologyandReproductiveBiology253(2020)331–332

ContentslistsavailableatScienceDirect

European

Journal

of

Obstetrics

&

Gynecology

and

Reproductive

Biology

(3)

RobertaAmadori

ObstetricsandGynecologyClinic,OspedaleMaggioredellaCarità

Novara,Italy

MartinaGerbino

ObstetricsandGynecologyClinic,UniversityofEasternPiedmont,

Italy

AnnalisaCuratolo

SCOstetriciaeGinecologia,OspedaleSant’Andrea,Vercelli,Italy

Danielasurico

ObstetricsandGynecologyClinic,UniversityofEasternPiedmont,

Italy

Received4August2020

Riferimenti

Documenti correlati

Monoclonal antibodies, designed to mimic the body’s natural immune response, are available as treatment for COVID-19 for patients at high risk of progression to severe disease..

Please cite this article as: Marzano AV, Genovese G, Response to “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of

Elena Zambrelli Epilepsy Center – Sleep Medicine Center, Childhood and Adolescence Neuropsychiatry Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy. *

On the basis of the findings collected so far, we hypothesized that the cytokine storm taking place in COVID-19 patients, deeply affecting endothelial functions, leads to

Also, to cope with the number of infected people, the weekly surgery ward was closed and dedicated to the management of highly suspect patients waiting for laboratory tests or mild

Following treatment with the MASP-2 inhibitor narsoplimab, all patients recovered and were able to be discharged from the hospital, further supporting the importance of

COVID-19, coronavirus disease 2019; MERS-CoV, Middle East respiratory syndrome coronavirus; ACE2, angiotensin-converting enzyme-2 receptor; ARDS, acute respi- ratory distress

The emerging spectrum of cardiopulmonary pathology of the coronavirus dis- ease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and re- view of autopsy findings from